Neutrophil-lymphocyte ratio may predict left atrial thrombus in patients with nonvalvular atrial fibrillation

Clinical and Applied Thrombosis/Hemostasis

Volumn 21, Issue 2, 2015, Pages 166-171

  Yalcin, Murat ^a   Aparci, Mustafa ^b   Uz, Omer ^a   Isilak, Zafer ^a   Balta, Sevket ^c   Dogan, Mehmet ^a   Kardesoglu, Ejder ^a   Uzun, Mehmet ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Etimesgut Military Hospital   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

atrial fibrillation; inflammation; left atrial thrombus; neutrophil lymphocyte ratio

Indexed keywords

ANTICOAGULANT AGENT; HEMOGLOBIN; BIOLOGICAL MARKER;

AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EOSINOPHIL COUNT; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LEFT ATRIAL THROMBUS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ATRIAL FIBRILLATION; BLOOD; COMPLICATION; ECHOGRAPHY; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; RISK FACTOR; THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOMARKERS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; RISK FACTORS; THROMBOSIS;

EID: 84923022404     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613503398     Document Type: Article

References (25)

1. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001 ; 86 (5). 516-521
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA. 2001 ; 285 (18). 2370-2375
3. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J. 2007 ; 28 (22). 2803-2817
4. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National registry of atrial fibrillation. JAMA. 2001 ; 285 (22). 2864-2870
5. Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet. 2009 ; 373 (9658). 155-166
6. Kaya MG, Akpek M, Elcik D, et al. Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers. Am J Cardiol. 2012 ; 109 (6). 851-855
7. Hijazi Z, Oldgren J, Andersson U, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy. Circulation. 2012 ; 125 (13). 1605-1616
8. Cingoz F, Iyisoy A, Demirkol S, et al. Carotid intima-media thickness in patients with slow coronary flow and its association with neutrophil-to-lymphocyte ratio: a preliminary report [Published online April 23, 2013]. Clin Appl Thromb Hemost. 2013 ;:
9. Demirkol S, Balta S, Unlu M, et al. Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness [Published online November 26, 2012]. Clin Appl Thromb Hemost. 2012 ;:
10. Bhat T, Teli S, Rijal J, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013 ; 11 (1). 55-59
11. Aschenberg W, Schlüter M, Kremer P, Schröder E, Siglow V, Bleifeld W. Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol. 1986 ; 7 (1). 163-166
12. Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (ESC). Europace. 2010 ; 12 (10). 1360-1420
13. Sadanandan S, Sherrid MV. Clinical and echocardiographic characteristics of left atrial spontaneous echo contrast in sinus rhythm. J Am Coll Cardiol. 2000 ; 35 (7). 1932-1938
14. Lip GYH. Can we predict stroke in atrial fibrillation?. Clin Cardiol. 2012 ; 35 (suppl 1). 21-27
15. Kamenský G, Drahos P, Plevová N. Left atrial spontaneous echo contrast: its prevalence and importance in patients undergoing transesophageal echocardiography and particularly those with a cerebrovascular embolic event. J Am Soc Echocardiogr. 1996 ; 9 (1). 62-70
16. Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol. 2005 ; 45 (10). 1638-1643
17. Balta S, Demirkol S, Celik T, et al. Association between coronary artery ectasia and neutrophil-lymphocyte ratio [Published online March 7, 2013]. Angiology. 2013 ;:
18. Karaman M, Balta S, Ay SA, et al. The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension [Published online January 4, 2013]. Clin Exp Hypertens. 2013 ;:
19. Uthamalingam S, Patvardhan EA, Subramanian S, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011 ; 107 (3). 433-438
20. Ertaş G, Sönmez O, Turfan M, et al. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. J Neurol Sci. 2013 ; 324 (1-2). 49-52
21. Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. 2012 ; 18 (11). 1478-1493
22. Hart RG, Pearce LA, Miller VT, et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis. 2000 ; 10 (1). 39-43
23. Bendriss L, Khatouri A. [Ischemic stroke. prevalence of cardiovascular causes documented by an extensive cardiovascular workup in 110 patients]. Ann Cardiol Angeiol (Paris). 2012 ; 61 (4). 252-256
24. Sasahara E, Nakagawa K, Hirai T, et al. Clinical and transesophageal echocardiographic variables for prediction of thromboembolic events in patients with nonvalvular atrial fibrillation at low-intermediate risk. J Cardiol. 2012 ; 60 (6). 484-488
25. Piccini JP, Stevens SR, Chang Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013 ; 127 (2). 224-232